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Abstract 
The paper investigates how sector composition and the magnitude of R&D investment in the EU may dif-
fer in 2020 in comparison to the past, if a selection of top R&D-investing SMEs were assumed to be on a 
fast growth track while the top R&D-investing large-scale companies continue to grow as before. The 
background of this research objective is the emerging focus on SMEs – and in particular the fast-growing 
among them – with regard to the "Europe 2020" policy strategy. The study relies on the sample of top 
R&D-investing firms as given by the latest available "EU Industrial R&D Investment Scoreboard" editions, 
building there from an unbalanced panel. Scenarios were developed by distinguishing SMEs' assumed 
growth paths vs. that of large scale companies. A linear prediction model has been used to calculate the 
scenario simulations. 
Overall, the study indicates that if one expects the (R&D-intensive) small firms to be a driving force for a 
substantial structural change in the EU economy, from being driven by medium-tech sectors towards a 
high-tech based economy, it requires either a significant longer-term horizon of the assumed fast growth 
track than the simulated 10 years, or small firms' growth figures which even exceed the assumed annual 
30% (as in the most optimistic scenario). Neither case appears to be particularly realistic. Hence, we need 
more top R&D investors in Europe to further intensify their engagement in R&D (increasing volume and 
R&D intensity) as well as numerous small firms that start and/or significantly increase their existing R&D 
activities and thus seek to become large firms and (global) leading R&D investors. Accordingly, a broad 
R&D and innovation (policy) strategy is needed with policy interventions which also target well all these 
options; i.e. stimulating firm growth and R&D and innovation-intensity across firm-sized classes.  
 
 
JEL Classification:  031, L11, L25, R38 
 
Keywords:  SME, company growth, industrial dynamics, structural change, R&D/innovation policy, 
Barcelona target, Europe 2020 
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Executive summary 
Problem: What specific problem does the study focus on? 
The paper seeks to investigate how sector composition and the magnitude of R&D investment in the EU 
may differ in 2020 in comparison to the past/present, if the top R&D-investing SMEs were assumed to be 
on a fast growth track while the top large-scale R&D-investing companies continue to grow as before. The 
background of this research is the emerging focus on the growth of innovative firms (thus especially 
SMEs) in terms of the "Europe 2020" policy strategy. 
Current understanding: What is known about this problem? 
The current understanding of small firms' growth and what policy can contribute in this regard relies 
widely on incomplete information, focusing mostly on the national and/or industry level or certain 
variables only assumed to determine growth (e.g. R&D, tax regimes, constraints in terms of factor 
endowments). In fact, a review of the recent economic and policy literature on the growth of innovative 
SMEs indicates that the EU shows – compared to the US – a higher share of absolute R&D expenditure 
made by SMEs, but on average SMEs in the EU are individually far less R&D intensive since they tend to 
engage in less R&D intensive sectors (medium- and low-tech). Further relevant findings from the literature 
are as follows: a) smaller firms tend to grow faster, are more R&D intensive and produce higher quality 
innovations, b) the optimal size-dependent type of R&D subsidy policy generally performs better than 
size-independent policies; c) supporting small firms' investment in R&D is often more growth-enhancing 
than subsidising large firms (e.g., Symeonidis, 1996; Akcigit, 2009; Coad and Hölzl, 2010; Moncada-
Paternò-Castello, 2011). 
Research question: What is the study's goal? 
The study's goal is to assess whether a substantial increase in spending on business R&D in the EU 
economy, and thus implicitly reducing the gap of private R&D investment between Europe and its 
competing economies (e.g. the US), may appear to be achievable within one decade (which is set out as a 
policy objective by the EU) if it is assumed to be driven by fast-growing SMEs. In this regard, the paper will 
address the following specific question: How would the sector composition and the overall volume of R&D 
investment in Europe differ in 2020 compared to the past/present if the (currently) top R&D-investing 
SMEs were assumed to be on a fast growth track while the top R&D-investing large scale companies may 
continue to grow as before?  
Design/methodology/approach: How was the study carried out? 
Empirically, this study relies on the sample of top R&D-investing firms as provided by the EU Industrial 
R&D Investment Scoreboard [SB] in the 2010 edition; i.e. the most recent firm level data referring to the 
accounting year 2009, which is taken as the starting point for individual firm level projections of steady 
growth paths over a period of 10 years, thus simulating the SB for 2020 [SB-2020]. Scenarios are 
distinguished for SMEs vs. large scale companies (assumed growth path) and with regard to high-, 
medium- and low-tech industries. Several SB waves have been merged in order to amplify the empirical 
base, resulting in pooled data of 2,000 companies (1,000 from EU and 1,000 from the rest of the world) 
over the period 2002 - 2009. A linear prediction model (according to e.g. Makhoul, 1975; Markham and 
Palocsay, 2006) has been applied to simulate three main future scenarios (and two alternative reference 
scenarios meant to benchmark the empirical results).  
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The limitations of this study (see Section 4.3) appear to be centred in the non-trivial assumptions with 
regard to the growth scenarios and a rather simplistic (linear) projection method, which is due to neglect 
of a number of other factors which are in truth relevant for firm and sector dynamics. 
Findings: What are the main outcomes? 
The main results of the scenario analyses are as follows: 
The simulated scenarios – distinguished according to the assumed growth of small R&D intensive 
companies – suggest that corporate R&D spending of the EU's SB companies will rise by a total of 70 - 
90% until 2020 in comparison to the figures from SB-2010 (depending on the assumed scenario and 
subject to a series of assumptions; see chapter IV). 
The ratio of Business Enterprise Expenditure on R&D [BERD]/GDP in EU-27 is expected to increase up to 
1.6 - 2.0% in 2020 and may thus be about to reach the Europe 2020 target in this regard (3% GERD, of 
which 2/3 should come from the business sector), if both the most optimistic firm growth scenario and in 
parallel the lowest scenario concerning GDP growth come true. 
The share of high-R&D-intensive sectors in terms of total expenditure on R&D in Europe is assumed to be 
increasing from 34% in SB-2010 up to at least 37% (low-growth scenario) and even 43% given the 
highest growth scenario. In turn, the shares of low- and medium-low-R&D intensive sectors are expected 
to remain virtually unchanged. Accordingly, and depending on the corresponding scenario assumptions, a 
gradual shift from medium-high towards high-R&D-intensive sectors should be expected for business 
expenditure on R&D in Europe. However, the structural gap of R&D investment between Europe and the 
US is not expected to close until 2020; at least not if assumed to be driven mainly/only by the growth of 
small firms. 
Contribution: What does the study add to current understanding? 
The study presented, by using a unique micro-data set and covering a representative sample of top-R&D-
performing firms for the EU as a whole, presents an ex ante appraisal of the order of magnitude of 
anticipated changes in terms of overall EU spending on business R&D and sector composition given 
several growth scenarios, distinguished according to company size. The results are expected to contribute 
to a better understanding of the potential impact which may arise from policy support targeted at 
company growth (sensitivity at macro-level/structural effects).  
Practical implications: Who will gain from the findings, why and how? 
As the simulated scenarios vary according to the assumptions concerning small firms' growth, the 
magnitude of the differences in the results provides a good grasp of the importance of small vs. large 
firms for certain sectors. Overall, the projection indicates that if one expects small R&D-intensive firms to 
be an engine for a substantial structural change in the European economy, from being driven by medium-
tech sectors towards a high-tech based economy, it requires either a significant longer time horizon for 
the assumed fast growth track than the 10 years simulated or small firms' growth figures which even 
exceed the assumed annual 30% (as in the most optimistic scenario). Neither case appears to be 
particularly realistic.  
Hence, from the empirical results of the study can be concluded that we need more top R&D investors in 
Europe to further intensify their engagement in R&D (increase volume and R&D intensity) as well as 
numerous small firms that start and/or significantly increase their existing R&D activities and thus 
become large firms and (global) leading R&D investors. Accordingly, we need policy interventions targeting 
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all these different options and therefore a broad R&D and innovation (policy) strategy; i.e. stimulating 
firms' growth and R&D and innovation-intensity regardless of firm size with appropriate/differentiated 
policy instruments. 
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1 Introduction 
Enterprises' competitiveness and individual growth is largely recognised as playing a pivotal role in terms 
of EU's economic prosperity. There is a conviction that (public and private) R&D represents one of the key 
elements that can push the EU towards a more knowledge-based, competitive economy; an argument 
which has been fully endorsed in the EU policy agenda where there is a revamping focus on private sector 
investment in R&D. This is, for instance, the case with regard to the "Europe 2020" policy strategy, which 
among other elements (i) confirms the Lisbon policy target (i.e. 3% of European GDP should be spent on 
R&D by 2010, and that two-thirds of this spending should come from the private sector), (ii) supports the 
design, implementation and assessment of targeted policy measures aiming at supporting the growth of 
European innovative firms, and (iii) aims to help (in particular) small firms to succeed through research 
and innovation.  
The objective of this study is to assess whether a substantial increase in spending on business R&D in the 
EU economy, thereby implicitly reducing the gap of private R&D investments between Europe and its 
competing economies1, may appear to be achievable within one decade (which is set out as a policy 
objective by the EU), if it is assumed to be driven by fast growing SMEs. In this regard, the following 
specific question will be addressed: How would the sector composition and the overall volume of R&D 
investment in Europe differ in year 2020 compared to the past/present, if the (currently) top R&D-
investing SMEs were assumed to be on a fast growth track while the top R&D-investing large scale 
companies continue to grow as before?  
 
After a brief overview of the literature (chapter II), in chapters III and IV the data base is discussed, 
several growth scenarios are developed, and the corresponding results of a linear projection model are 
presented. Chapter V summarises possible implications for EU policy making. 
 
2 Literature review  
There is ample literature on firm growth, the role R&D and innovation play in this respect and the link 
between company size and corresponding growth paths (see, for example, Acs (1990) and Audretsch 
(2006)). There is also evidence suggesting significant differences in firms' growth distribution in different 
countries (see e.g. Junge and Kaiser, 2004; Bartelsman et al, 2005).  
In general, economists have long been studying the link between technological innovation and economic 
growth. This research has been driven by Schumpeter’s (1934) description of technological innovation as 
the source of economic growth. But what is the relative contribution to growth made by small compared 
to large high-tech firms?  
Reviewing the existing literature concerning the contribution of firms (distinguished by their size) to global 
innovation and public policy uncovers three relevant facts: a) smaller firms tend to grow faster, are more 
R&D intensive and produce higher quality innovations, b) the optimal size-dependent type of R&D subsidy 
policy generally performs better than size-independent policy, c) supporting small firms' investment in 
 
1  According to European Commission & EUROSTAT (2011), the US in 2008 had business sector expenditure on R&D [BERD] of 2% GDP compared to 1.2% in the EU-27.  
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R&D is often more growth-enhancing than subsidising large firms (e.g., Symeonidis, 1996; Akcigit, 2009; 
Coad and Hölzl, 2010). 
Numerous empirical studies analysing firms' growth patterns show that emerging firms seem to grow 
much faster in the US than in Europe. In addition, firms in the EU, especially smaller companies, exhibit a 
reduced ability for growing beyond certain size thresholds, especially when entering into new, knowledge-
intensive sectors and sustaining growth (Hoffmann and Junge, 2006). Nonetheless, according to a recent 
study by Bravo-Biosca (2010), unsuccessful US firms also shrink much faster than corresponding EU 
firms, and yet the EU has a much larger share of stable firms for which employment has not varied too 
much (upwards or downwards) in recent years.  
In fact, reviewing the recent economic and policy literature on the growth of innovative SMEs indicates 
that the EU shows – compared to the US – a higher share of absolute R&D expenditure carried out by 
SMEs, but on average the EU SMEs are far less R&D intensive as they tend to engage in less R&D 
intensive sectors (medium- and low-tech). Further literature (e.g. Acs et al., 2008) indicates that although 
the EU group of SMEs is larger (in terms of the number of enterprises and the overall number of 
employees), in terms of absolute new job creation a smaller group of large high-growth enterprises is at 
least equally important as the high-growth SMEs.2  
With regard to the possible cause of the EU vs. US R&D intensity gap, divergent findings arose from the 
literature. For instance, Moncada-Paternò-Castello et al., 2010 found that the lower overall corporate R&D 
intensity for the EU is the result of sector specialisation (structural effect). Indeed, the US has a stronger 
sectoral specialisation in the high R&D intensity sectors (especially ICT-related) compared to the EU. 
Moreover, the US seems to have a much larger population of smaller (also younger)3 firms in these high 
R&D-intensive sectors, which leads to higher overall investment in R&D as well as certain differences in 
terms of common company characteristics. The aforementioned study thus confirms the finding by other 
authors (Mathieu and Van Pottelsberge de la Potterie, 2008, Van Ark et al., 2003). However, such results 
contradict other studies (e.g. Erken and van Es, 2007; Pianta, 2005; van Reenen, 1997), which conclude 
that the R&D intensity gap is rather due to firms' underinvestment in R&D (intrinsic effect).  
The literature also offers the results of several exercises to simulate R&D expenditure growth by both the 
private and public sector. For example, Brécard et al. (2004) used the Nemesis European macro-
econometric model to determine the various economic mechanisms involved in the effects of innovations 
in competitiveness, employment (total and in research), growth and public authority budget, in relation to 
the 3% GDP target for research in Europe. In another study, Gardiner (2010) simulated R&D investment 
scenarios and thus calibrated the impact on a set of multi-country models, also considering the R&D 
investment targets set by the Lisbon Strategy. Data was collected from the available input-output, 
sectoral, R&D, and macro data. The model simulations provided the likely impacts of targeted R&D 
increases on GDP growth, employment, unemployment, sectoral production, trade, prices, public finance, 
etc. in different Member States and the EU25.  
However, to our knowledge there are no future-oriented scenario analyses using simulation/projection 
techniques – which are based on micro-data at EU level – aimed at researching whether the faster growth 
of R&D-intensive enterprises (SMEs vs. large companies) reduce the EU R&D intensity gap within this 
decade(s), thus shedding light ex ante on the possible outcome of policies targeting fast growth in SMEs. 
An overview about corresponding policy measures is given in Lilischkis (2011): Policies in support of high-
 
2  For an extended literature review in this regard, see for example Vinnova (2008) or Moncada-Paternò-Castello et al., (2010). For literature on firms’ dynamics and economic competitive-
ness see for instance Bosma and Levie, 2010 and Teruel and de Wit, 2011. 
3  In fact, Cincera and Veugelers (2010) found that younger companies (i.e. those created from 1975 onwards) show higher R&D intensity than the older ones and are more numerous in the 
US than in the EU. Moreover, the younger companies based in the EU are less R&D intensive than their US counterparts. Altogether these factors explain to a large extent the overall lower 
R&D intensity of EU companies. 
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growth innovative SMEs. An inventory of R&D and innovation policies (in the EU and elsewhere) is provided 
in http://erawatch.jrc.ec.europa.eu/.  
3 Data 
3.1 The EU Industrial R&D Investment Scoreboard database 
In general, the EU Industrial R&D Investment Scoreboards [SB] collect data from the latest audited 
company reports and accounts published up to 1 August in the previous year. It also encompasses data 
for the three previous reporting years. The SB's list companies whose registered offices are located within 
the EU (in total 1,000) and the same number with registered offices outside the EU. These companies are 
considered to be the top R&D investors for each of their respective EU and non-EU groups and account for 
a significant share of overall Business Expenditure on R&D [BERD]. For instance, the total investment in 
R&D of the 1,000 EU companies listed in the SB-2010 corresponds to 88.4% of total BERD in EU-27 
(statistical year 2009).  
Admittedly, the concepts of capturing investment in R&D in BERD and SB are different, which makes the 
direct comparison of the two figures difficult.4 However, comparing the volumes of R&D investment as 
represented by SB firms may help us to understand the order of magnitude. In fact, as BERD is mainly 
driven by domestic firms (in Europe SB companies account for ~80% of BERD)5, by projecting the growth 
paths of the leading R&D investors in Europe and simulating the SB-2020 we may get a fair grasp of the 
anticipated changes in terms of BERD too (although neglecting structural changes in terms of territorial 
in- and outflows of R&D investment, i.e. the impact of a possibly increasing globalisation of corporate 
R&D and innovation activities, ceteris paribus). 
 
3.1.1 R&D-intensive SMEs within the R&D Investment Scoreboard 
In general, the majority of SMEs in Europe do not carry out their own R&D activities.6 Of those few firms 
which actually do, only the very top investors make it into the SB (due to the very nature of the 
Scoreboard of crowding out smaller firms; see above). Hence, the SMEs in the sample are somehow 
'exotic' within a sample of fairly specific firms. By no means can the overall sample (and especially not 
the SMEs within) be seen as representative of the entire population of companies in Europe. This should 
always be kept in mind when interpreting results and possibly generalising from empirical findings 
resulting from this data.  
The latter holds in particular if – like in this study – small firms' growth is a matter of interest. In order to 
distinguish firms as 'small' and 'large' for the simulation of growth scenarios, the pooled SB-2010 sample 
has been scanned for companies which at any year had to be classified as SME; no matter whether they 
have grown later beyond the size of an SME (see Appendix I for a discussion of 'fast growing companies in 
SB' and Appendix II for 'SMEs in SB'). This means that in the base year of the projections (2009) – among 
the companies considered as SME – there might be some companies which already had grown well 
                                                 
4  While the SB provides figures at consolidated firm level (regardless of where the investment in R&D is taking place), BERD is a territorial concept providing the sum of R&D invested within 
a certain area (thus also taking into account in- and outflows).   
5  See  Azagra Caro and Grablowitz (2008). More recent data on this has been just published together with SB-2011. 
6  Spielkamp and Rammer (2006), analysing a sample mostly consisting of SMEs, concluded that across Europe about one out of four manufacturing firms and about one out of three firms 
in knowledge-intensive business services (KIBS) are engaged in R&D activities (with significant regional differences).  
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beyond SME size. Nevertheless, they are 'stigmatised' as small and medium sized companies in order to 
distinguish their growth paths from those of the large/mature companies.  
Recall the definition of SME: >250 employees and net sales <50 mill Euros within a given year.7 
Companies which are hereinafter considered as an SME have to fulfil these two joint criteria in at least 
one year from 2002 to 2009 (coverage of the SB waves until SB 2010).  
 
3.1.2 Representativeness & sample selection bias 
As outlined above, there is a general bias in SB towards larger companies (more relevant for the 'rest-of-
the-world-sample' than for the European one, but still notable in the EU, too)8 due to the very nature of a 
scoreboard including companies according to an absolute number (in the given case volume of R&D 
investment). Moreover, as the scenarios distinguish between the growth of large and smaller companies – 
which takes the focus onto SMEs – certain problems with representativeness arise since only very few and 
to some extent rather specific SMEs are listed in the SB (for a discussion of SMEs in the SB see Appendix II 
and e.g. Ortega et al., 2009).  
Taking exemplary data from SB-2010, complemented by data from SB-2006 (i.e. pooled SB data, 
hereinafter named Sample 2; details described in Appendix II), altogether 160 'small firms' were found, i.e. 
160 firms were classified as SMEs at any point in time from 2002 to 2009. Among these 160 firms, 133 
belong to the top 1,000 EU Scoreboard companies and just 27 are from the 'non-EU' top R&D investors.9 
In fact, smaller firms tend to be crowded out with rising geographical coverage and, accordingly, any 
direct comparison of sectoral distribution between the EU and the 'rest-of-the-world' [RoW] sample in 
terms of SMEs may appear misleading, due to the sample size and coverage bias, and is therefore 
generally disregarded hereinafter.  
 
3.2 Data processing  
As mentioned above, the data set this study relies on was obtained from different SB editions from 2004 
to 2010. In order to create this sample, starting with the 2,000 companies listed in the SB-2010 and 
going backwards in time to observations for 2002, the initial data set has been complemented by 
including data from earlier SB waves, thus accepting that the resulting panel will be unbalanced 
(increasingly lacking observations for earlier years). The projections of SB-2020 are restricted to EU 
companies' growth scenarios only.  
 
3.2.1 Exchange rate adjustments 
In each SB all monetary values are provided in Euros. Exchange rates to be applied for those firms not 
reporting in Euros are assumed to be the end of the year exchange rate into Euros of the currency the 
company is reporting in. This conversion rate then is applied to each reported year. In order to be able to 
join the annual SB waves together, each monetary value of companies not reporting in Euros had to be 
                                                 
7  According to the definition (see: http://ec.europa.eu/enterprise/policies/sme/facts-figures-analysis/sme-definition/index_en.htm), an "SME", moreover, has to have a total balance sheet of ≤ 
€43 mill Euros. However, the latter is not taken into account here due to lack of information on Scoreboard company balance sheets. 
8  The underlying reason relates to the differences in sample coverage when focusing on the main R&D investors globally rather than EU-wide only. 
9  All from the USA; belonging to the Pharmaceutical & Biotech (25), Health (1), and Telecom (1) sectors. 
 
IPTS WORKING PAPER ON CORPORATE R&D AND INNOVATION - 01/2012 
PROJECTION OF R&D-INTENSIVE ENTERPRISES' GROWTH TO THE YEAR 2020: IMPLICATIONS FOR EU POLICY? 
 
 
 
 11
converted into the 'original values' (reported currency) and then – by applying the exchange rate reported 
in SB-2010 – back into Euros, thus resulting in values equivalent to 2010 Euros. By using this procedure a 
further price adjustment of the monetary values of non-Euro companies was no longer necessary.  
 
3.2.2 Price adjustments (companies reporting in Euros) 
All monetary values of companies reporting in Euros were given in current Euros, and therefore had to be 
price adjusted (correction for inflation). In order to do this, the Industry Producer Price Index (PPI) for the 
EU, as provided by EUROSTAT (2011), was used (resulting in constant 2010 Euros). For a discussion of 
possible bias introduced due to the selection of conversion/exchange rate/price adjustments, see the 
technical annex to the analytical SB reports. 
 
3.3 Descriptive statistics 
As a result of pooling several annual editions of the EU Industrial R&D Investment Scoreboard, several 
different longitudinal sample(s) of R&D-intensive companies were obtained (different in terms of their in-
/exclusion of observations with missing values/blanks for certain years). For details, see the description of 
samples S-1, S-2, and S-3, provided in Appendix II.  
For this study, the S-2 sample will be used,10 as it constitutes an unbalanced panel of a total of 160 
small firms out of the 2,000 companies listed in SB-2010 (133 SMEs from the EU). Tables 1 and 2, 
Appendix II, provide descriptive statistics, broken down according to firm classes and sample selection 
procedure. Recall: For the scenario projections only EU firms are considered! 
Evidence from Table 1 suggests that large-scale R&D-intensive companies can basically be found in any 
sector of economic activity, whereas R&D-intensive SMEs are mainly linked to five emerging sectors only 
(frequency >3%), namely Electronic & Electrical Equipment, Healthcare Equipment & Services, Technology 
Hardware & Equipment, Software & Computer Services, and Pharmaceuticals & Biotechnology. From Table 
2, Appendix II, it can be seen that firm characteristics are quite different when comparing R&D-intensive 
SMEs and large-scale R&D-intensive companies, which suggests significant firm/size effects. For instance, 
the operating profits of R&D-intensive SMEs – in contrast with large companies – appear on average to be 
even negative. This gives reason to generally distinguish SMEs from other companies for the growth 
projection scenarios.  
Apart from differences attributable purely to company size (such as the number of employees, net sales, 
capital expenditures, R&D investment, etc.) some common patterns stand out from the descriptive 
statistics. For example, R&D intensity tends to be higher in small firms (this is not surprising given the 
underlying sample selection of the largest nominal investors in R&D), while profits in average across all 
SMEs even appear negative (see Table 2, Appendix II).  
                                                 
10  Given the three alternative sample options (see Appendix), S-2 corresponds to the least strict assumptions. In fact, relying on S-1 (balanced panel) would mean reducing the number of 
firms to be considered (to a total of 1375) and in particular the number of SMEs (to 4% only). In turn, S-3 may provide additional information concerning small firms in earlier years but 
would not widen the sample of firms used for the projections (base year 2009). S-2 instead has a clearly defined cut-off point in terms of R&D investment (SB threshold for 2009); data 
for 2009 – the starting point for projections – is available for all companies, and there are in total exactly 1,000 companies in Europe. NB: For SME survival and growth path analyses, S-3 
could appear to be more appropriate (unbalanced panel). S-1, since it is a balanced panel, may serve rather, for instance, for calibrating growth models and/or researching the impact of 
environmental variables in terms of SME trajectories.  
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In general, the descriptive statistics already allow some important conclusions to be reached: Firstly, R&D-
intensive SME's are fairly special. In fact, they differ from 'normal' SMEs and from other R&D-intensive 
companies not only in terms of R&D investment but also in growth patterns and possibly even in terms of 
their underlying business model, as, for instance, outlined by Ortega-Argilés et al (2009). Secondly, sector 
specifics appear to be prominent among R&D-intensive firms, which is all the more reason for a more 
detailed analysis of particular firm groups (e.g. along certain R&D intensity groups such as high-tech 
industries, medium high/low, low-techs) and – at the same time – points towards the need for support 
measures tailored to sector-specifics. 
The sector-wise consideration of descriptive statistics, as presented in Table 3, Appendix II, proves the 
heterogeneity of SMEs and the above-mentioned significant sector specifics, which both together may 
imply analysing business concepts, company growth patterns, survival rates, etc. sector-wise too. However, 
for the envisaged projection of company growth paths – first of all – sector-independent scenarios are 
assumed. This will possibly be changed in future studies, when going into more detailed analyses, but it is 
generally limited by the given sample due to the comparably low number of SMEs assigned to each of the 
individual sectors. 
 
4 Methodological approach 
4.1. Scenario building 
In order to provide an outlook on potential growth paths of R&D intensive firms in the EU and on the cor-
responding tentative impact on the sector composition of the EU economy (high-, medium-, and low-R&D 
intensity sectors), individual firm level projections of steady growth paths over a period of 10 years are 
computed by applying a linear projection model (see below for details).  
This study therefore relies empirically on the sample of top-R&D-investing firms as given by the SB-2010 
edition (i.e. the most recent firm level data referring to the accounting year 2009, which is the starting 
point of the projections). Several SB waves have been merged in order to amplify the empirical base 
(pooled data, see above for a description of the data base). 
As a result of the projections – distinguished according to several scenarios (defined below) – the Score-
board for year 2020 is simulated (target year); hereinafter called SB-2020. In this regard we shall look at 
how sector composition and the magnitude of R&D investments in Europe may differ in 2020 – compared 
to the image provided by the SB-2010 – if the SMEs within the SB are assumed to be on a fast growth 
track while the remaining (larger) companies continue to grow as before (extrapolation of their past 
growth paths).  
The projections envisaged for firm development (EU firms only!) are subject to a number of non-trivial 
assumptions. For instance: 
 All companies may grow at the same rate in terms of employment and sales. 
This assumption is non-trivial as one might argue that a company could grow faster in terms of sales 
than employment (or the other way round). Although this is certainly possible in the short run, it is 
assumed that in the mid to long run the growth paths of sales and employment of a certain company 
may appear virtually the same (thus implicitly assuming constant returns to scale and full technical 
efficiency at any time). However, the admittedly fairly strict assumption of equivalent growth rates in 
terms of sales and employment had to be made since simulating fast growth in terms of sales only 
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was assumed to provide a biased picture, as a number of SMEs report sales figures close/equal to ze-
ro11 and projecting a growth scenario (only) based on these figures likely would have provided mean-
ingless results. 
 The company level R&D intensity (R&D/sales ratio) is assumed to remain constant. 
This assumption tends to introduce a bias towards overestimating R&D intensities in the projected 
scenario. In fact, small firms in SB have higher R&D intensities than the large firms (see e.g. R&D in-
tensities in different samples of SMEs in SB vs. all SB firms as reported in Table 2, Appendix II) and – 
given this evidence – there is reason to believe that R&D intensity decreases over a firms' growth his-
tory (asymptotically rather than linear). Hence, by assuming constant R&D intensities in small firms – 
even in case of rapid growth – the simulated volume of R&D investments in the target year tends to 
be overestimated. However, assuming firm specific paths of R&D intensities based on the comparably 
short time series of observations available – particularly with regard to smaller SB firms – appeared 
to be impossible (this could possibly be the subject of a future refinement of the study). Hence, we 
had to rely on the assumption of constant intensities (i.e. R&D/sales ratios). Furthermore, in order to 
avoid a bias resulting from an impact of the financial crisis on R&D intensities, instead of the most re-
cent available year the projections are based on the firm-specific R&D intensity of 2007 (pre-crisis).12  
 A company is considered to be 'small' (and – with regard to the projections – therefore implicitly on a 
fast growth track) if it had to be classified as an SME in any year between 2002 and 2009. In other 
words: A firm that was an SME in the base year of the projection (2009) and another which has al-
ready grown well beyond the corresponding threshold from being an SME at any time from 2002 to 
2009 would both be assumed to be on a fast growth path. 
This assumption relies on an empirical investigation of 'fast growth' among the SB firms (presented in 
Appendix I). In fact, the fastest growing firms in Europe appear to be the smaller companies whilst in 
the US and even more evidently in the Rest of the World sample the fast growing companies are 
rather the large ones. Hence, in order to simulate the growth path of R&D intensive firms in Europe up 
to 2020 more appropriately, we have pooled the potentially fast growing firms (the current SMEs) and 
also those which are already growing fast in Europe (companies which recently grew beyond SME 
thresholds) and – by that means – form a sample which actually comprises firms of different sizes 
(see descriptive statistics below and Tables 2 & 3, Appendix II). 
 SMEs and large scale companies are growing at a different speed. 
All European companies not classified as 'small firms' (i.e. which were not an SME at any point be-
tween 2002 and 2009, see point above and chapter III concerning details of the dataset) are assumed 
to be growing at an annual growth rate of 5.8%, which is the average employment growth rate 
across all large EU companies in SB-2010 (CAGR employment 8yrs).13  
 For the growth of small firms the following growth scenarios were computed:14 
                                                 
11  See Appendix II for SMEs in SB or the related discussion in e.g. Ortega-Arquiles et al (2009). 
12  In case of reported zero sales or missing values for 2007, the average for the corresponding sector group has been assumed (thus distinguishing high, medium-high, medium-low and low-
tech). Moreover, for high-tech firms R&D/sale ratios above 10 (i.e. 1000%) were considered as outliers and set to 10 by default (NB: all corresponding 'outlier' companies are SMEs from 
the Pharma & Biotech sector).   
13  Employment CAGR 8yrs across all 2,000 SB firms: 6.1% (EU only: 7.1%); large scale firms in EU: 5.8%, in RoW: 4.8% (all large firms together: 5.3%); SMEs in EU: 15.0%, SMEs in RoW: 
12.6% (all together: 14.6%). 
14  NB: Computing a scenario of 5% annual growth for small companies was skipped as it would be much lower, given their current growth path (and even lower than the reference scenario R-
II, assuming an equal growth rate of 7.1% employment CAGR 8yrs across all EU companies; thus disregarding firm size).  
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Scenario (A):  R&D intensive small firms in the SB will grow at 10% per year until 2020; 
 NB: the average annual employment growth rate calculated for the corresponding sample 
of firms for the period 2002 – 2009 was 15%! Hence, assuming 10% annual growth for 
the projection of 2020 – i.e. Scenario S-A – implicitly represents an under-proportional 
growth, given the empirical evidence from the past (and to this extent not really a 'fast 
growth track'). 
 
Scenario (B):  20% annual growth rate; 
 Implicitly this scenario corresponds to the definition of a fast-growing firm as agreed by 
OECD & EUROSTAT: A company is classified as being 'fast-growing' if in a consecutive 
three year period in each of these years a minimum of 20% increase in either sales or 
employment is achieved.15 
 
Scenario (C): 30% annual growth rate; 
 
Reference scenario R-I: 
In order to assess the empirical results of each scenario a reference scenario R-I is computed, assuming 
an annual employment growth of 5.8% (8yrs CAGR) for large SB companies and 15% annual employ-
ment growth for small firms (8 yrs CAGR). Given these assumptions, the reference scenario has to be seen 
between the scenario A and B as set out above. 
 
Reference scenario R-II:  
All companies may grow at the same growth rate of 7.1% (un-weighted average 8 yrs. employment CAGR 
across all EU SB firms) regardless of the corresponding company size. 
 
 
4.2 Projection model 
A linear prediction model has been applied to simulate each of the three main future scenarios (thus fol-
lowing, for instance, Makhoul, 1975; Strobach, 1990): 
 
Where          is the predicted value, and                    the previous observed values, and         the 
growth coefficients.  
 
4.3 Acknowledgment of limitations 
The outlined methodology appears to suffer from two main threats, namely strong (and somewhat unre-
alistic) assumptions with regard to the growth scenarios and a rather simplistic (linear) projection method 
which is due to the neglect of a number of impact factors that are relevant for firm and sector dynamics. 
We are fully aware of these shortcomings and acknowledge them briefly below. 
  
                                                 
15  See: OECD-EUROSTAT (2005). 
14
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 Macro-economic cycles and possible external market shocks are not reflected in the scenarios out-
lined, although they would certainly affect the growth paths of companies and, given the time 
span of 10 years, are quite likely to play a role. 
 Assuming constant growth rates at a firm level for both small and large firms neglects the exis-
tence of business cycles and individual firm specifics in terms of growth paths. In fact, empirical 
evidence of individual firm growth paths suggests non-linear trajectories; i.e. after a period of fast 
growth, lower or even flat/negative growth figures might be seen.  
 Likewise, the assumption of constant growth rates and/or constant R&D intensities somehow col-
lides with the idea of industrial dynamics driven by creative destruction. In fact, fundamental in-
novations may cause a certain technology/industry to become obsolete while another is cre-
ated/rising. Whether overall spending on R&D in such a case in-/decreases or remains constant 
cannot be answered in general. Hence, any implementation of these aspects in the scenarios is 
non-trivial and was therefore skipped here for the purpose of simplification. For the same reason, 
a possible impact due to increasing internationalisation of corporate R&D has been left out, and 
no sector differences have been assumed for the growth scenarios (this could be the subject of 
further refinement in the study).  
 With regard to assuming constant growth rates, moreover, the time span of 10 years under con-
sideration appears to be problematic. In fact, a persistent growth differential between small and 
large firms would encourage the management of larger (presumably slower growing) companies 
to react, which tends to stimulate mergers and acquisitions [M&A]16; i.e. the composition and size 
distribution of the sample analysed would dynamically change.  
 The assumptions on GDP growth rates until 2020 (relevant for calculating the BERD/GDP ratio) 
have not been endogenised. In fact, there is no distinction according to the 3 scenarios, although it 
appears likely that – if e.g. the most optimistic growth scenario turns out to be true – the corre-
sponding GDP figures would be at the upper end of the anticipated corridor (2 – 3% annual 
growth) or eventually even go beyond it.  
 As no simulations for the sector composition of the Rest-of-the-World sample have been made, 
the comparison of structural change (sector composition) of the simulated SB-2020 has to be 
made with a historical image (SB-2010). However, non-EU economies are likely to develop further 
too and the economic structure may change accordingly. Hence, the benchmark is not static.  
 Finally, given that there is a significant population of fast-growing R&D-intensive companies (as 
assumed in the scenarios), it appears likely that numerous spillover/spin-off effects may occur, 
leveraging overall spending on R&D and innovation. However, given the nature of the data set 
such an effect would not be captured (due to the entry threshold of SB).17  
 
Given all the mentioned limitations, it should be recalled that the aim of the projection exercise presented 
is – rather than providing the most accurate forecast possible – to illustrate the order of magnitude of a 
potential rapid growth of R&D intensive SMEs and how the aggregate sector composition in the EU's 
economy may change accordingly. For the study presented the crucial question is how the empirical re-
sults might be affected by the above-mentioned methodological threats.  
 
16  Although empirical evidence suggests a significant growth differential between large and smaller (R&D intensive) companies (see Appendix I), in fact, large R&D-intensive companies would 
probably not stay aside and observe smaller companies growing rapidly over such a long period, thus challenging the larger companies in their markets/market positions. A series of M&A 
would likely occur (larger firms taking over smaller companies).  
17  Amplifying the empirical scope (e.g. using S-3 instead of S-2) would likely not result in significant changes concerning the projections of overall spending on R&D (order of magnitude) or 
the sector composition because the additional companies are simply too small and invest too little in R&D (individually as well as aggregate). 
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Taking the most optimistic S-C scenario as a benchmark, and addressing all the above-mentioned limita-
tions by implementing more realistic assumptions and a distinctive methodology – with the exception of 
the last point (significant spillovers due to many fast-growing R&D intensive firms which may cause posi-
tive multiplier effects) – would rather tend to lower the expectations concerning an overall increase of 
corporate R&D spending in the EU and an accelerated structural change towards high-tech/knowledge-
intensive sectors. In other words, if taking all points mentioned above on board (which would likely make 
the projection non-operational), the order of magnitude of the corresponding results should be expected to 
be lower than the projection of the S-3 scenario, but likely still above S-A, i.e. the order of magnitude has 
to be expected anyway within the bandwidth rendered by the empirical results due to the scenarios out-
lined (S-A <> S-C).   
5 Results 
Table 1 below presents the main results of the simulation of SB-2020; i.e. the projections of R&D invest-
ment by sector groups given the specific scenario assumptions (S-A: 10% p.a. growth of small companies; 
S-B: 20%, and S-C: 30%). Moreover, the two reference scenarios presented, R-I (growth p.a.: small firms 
15%; large: 5.8%) and R-II (all firms grow at 7.1% p.a.) may help in assessing the S-A, S-B, and S-C sce-
nario results.  
 
Table 1: Results of scenario projections 
 
 
SB 2010 
 
 
R-I 
SB 2020  
reference  
scenario  
R-II 
SB 2020 
reference 
scenario 
SB 2020  
Scenario A 
(+10% p.a.) 
SB 2020 
Scenario B 
(+20% p.a.) 
SB 2020  
Scenario C 
(+30% p.a.) 
R&D investment by SB 
companies from EU  
(million/billion Euro) 128bn % 224bn % 219bn % 220bn % 228bn % 244bn %
Pharma & Biotech 20397 15.9 43123 19.3 36308 16.0 41086 18.6 46133 20.2 56785 23.3
ICT related 19070 14.9 33274 14.9 33488 14.8 32485 14.7 34441 15.1 38571 15.8
Other high 3970 3.1 8195 3.7 6987 3.1 8100 3.7 8337 3.7 8839 3.6
Automobile & parts 27408 21.4 41035 18.3 55185 24.3 41030 18.6 41043 18.0 41070 16.8
Electronic & Electricals  6994 5.5 10002 4.5 12528 5.5 9960 4.5 10064 4.4 10283 4.2
Chemicals 7473 5.8 11537 5.2 13595 6.0 11532 5.2 11544 5.1 11569 4.7
Aerospace & Defence 7998 6.2 16018 7.2 14668 6.5 16000 7.2 16044 7.0 16136 6.6
Other medium-high 12073 9.4 19147 8.5 19671 8.7 19093 8.6 19226 8.4 19508 8.0
Medium-low-tech  9487 7.4 14336 6.4 14689 6.5 14328 6.5 14349 6.3 14396 5.9
Low-tech 13106 10.2 26922 12.0 20274 8.9 26918 12.2 26927 11.8 26946 11.0
BERD/GDP [%] subject to  
assumed GDP growth#       
2% annual GDP growth ESTAT 1.25 1.8  1.8  1.8  1.8  2.0
2.5% annual GDP growth  1.7  1.7  1.7  1.7  1.9
3% annual GDP growth  1.6  1.6  1.6  1.7  1.8
 
NB: Sectors are split into four groups according to the worldwide R&D intensity of the corresponding sector: 
 
High R&D intensity sectors (intensity above 5%) include e.g. Pharmaceuticals & biotechnology, Health care equipment & ser-
vices, Technology hardware & equipment and Software & computer services. 
Medium-high R&D intensity sectors (between 2% and 5%) include e.g. Electronics & electrical equipment, Automobiles & 
parts, Aerospace & defence, Industrial engineering & machinery, Chemicals, Personal goods, Household goods, General industri-
als, Support services. 
Medium-low R&D intensity sectors (between 1% and 2%) include e.g. Food producers, Beverages, Travel & leisure, Media, Oil 
equipment, Electricity and land line telecommunications. 
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Low R&D intensity sectors (less than 1%) include e.g. Oil & gas producers, Industrial metals, Construction & materials, Food & 
drug retailers, Transportation, Mining, Tobacco and Multi-utilities.  
For details see European Commission: The 2010 EU Industrial R&D Investment Scoreboard 
 
Relying on the empirical results of the scenario projections, Table 1 also illustrates what the presented 
growth scenarios may imply for Business Expenditure on R&D [BERD] figures in the EU-27 related to the 
corresponding GDP (see: 'Europe 2020 Indicator').18 Thus, the estimation of BERD/GDP relies on the non-
trivial assumption of a time-invariant multiplier for SB firms' R&D investments in relation to the overall 
BERD of the EU-27. This assumption implies that over the period of the scenario projections no significant 
changes in terms of representativeness of SB firms for overall corporate R&D investment in the EU-27 
will occur and, moreover, that there will be no changes in terms of relative volumes of in-and outflows of 
R&D investment regarding the EU territory (e.g. due to increasing globalisation of corporate R&D and in-
novation activities). Both assumptions are far from being trivial and might be the subject of further dis-
cussion and refinement. Nevertheless, when testing the sensitivity of the simulated BERD/GDP shares for 
all scenarios (empirically tested for various SB multipliers) the results calculated appear to be robust 
(which is most likely due to the overwhelming importance of the top R&D investors in Europe for the over-
all business expenditure on R&D in the EU). 
The reference point for shifts in terms of the sector composition of R&D investment volumes (as sug-
gested by the projection results) is presented in Graph 1 below, which illustrates the current R&D invest-
ment shares by sector groups in the EU and other world regions as given by SB-2010.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
18  Note: the BERD/GDP share for EU-27 was calculated for 2009 and related to the corresponding share of SB firms' R&D investment in terms of EU-27 GDP, which provides an estimator of 
overall BERD in the EU-27 on the base of the SB-2010 firms' R&D investments (EU-27 BERD volumes = 115% of SB-2010 EU firms' R&D investments, i.e. SB R&D volumes refer to c. 86% 
of BERD in Europe).  
 
IPTS WORKING PAPER ON CORPORATE R&D AND INNOVATION - 01/2012 
PROJECTION OF R&D-INTENSIVE ENTERPRISES' GROWTH TO THE YEAR 2020: IMPLICATIONS FOR EU POLICY? 
 
 
 
 
Figure 1: R&D investment shares by sector group and world region (acc. to SB-2010) 
US (€138bn)EU (€128bn)
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Source:  The 2010 EU Industrial R&D Investment Scoreboard; European Commission, JRC/DG RTD 
NB:   The sector compositions as illustrated in Figure 1 (as well as all the scenarios outlined above) include all 1,000 EU SB 
companies. However, for an exact comparison of R&D investment shares by sector groups between the EU and those of 
other world regions (implicitly comparing the 1,000 EU firms to the 1,000 SB firms belonging to the RoW sample) one 
should ensure that 'similar firms' are being compared, i.e. the threshold for inclusion into the SB should be the same for 
both samples. It is in fact lower for the EU sample due to the sample size bias, as discussed above in chapter III. Figure 
4 in the SB-2010 Report illustrates the corresponding figures under the assumption of identical R&D investment thresh-
olds (in which case the EU sample constitutes only c. 400 firms). Nevertheless, comparing the aggregate sector shares 
as presented above with those in Figure 4 SB-2010 suggests no significant differences (the numbers are virtually the 
same), which indicates overall fairly robust results in this regard and presumably also with respect to the corresponding 
results of the scenario analyses. 
 
Figure 2 illustrates the simulated Reference Scenarios R-I and R-II in order to allow benchmarking for indi-
vidual scenario results (presented in Figure 3) and especially assessing their differences.  
 
 
 
 
 
Pharma & Biotech
ICT-related
Other high
Automobiles & parts
Electronic & Electrical 
Equipment
Chemicals
Aerospace &
 defence
Other medium-high
High Medium-High Medium-Low Low
34%
10% Pharma & 
Biotech
ICT-related
Other high
Automobiles 
& parts
Electronic & 
Electrical 
Equipment
Chemicals
Aerospace & 
defence
Other 
medium-high 1%3%
7%
28%
68%49%
RoW (€53bn)
Other 
medium-high
Aerospace & 
defence
Chemicals
Electronic & 
Electrical 
Equipment Automo-biles 
& parts
Other high
ICT-related
Pharma & 
Biotech
6%
11%
45%
38%
Japan (€89bn)
Other medium-
high
Chemicals
Electronic & 
Electrical 
Equipment
Automobiles & 
parts
Other high
ICT-related
Pharma & 
Biotech
4%
4%
39%
53%
 
IPTS WORKING PAPER ON CORPORATE R&D AND INNOVATION - 01/2012 
PROJECTION OF R&D-INTENSIVE ENTERPRISES' GROWTH TO THE YEAR 2020: IMPLICATIONS FOR EU POLICY? 
 
 
 
 
Figure 2: Reference Scenarios 
 
 
EU: R-I (€224bn)
assumed grow th p.a.: small f irms 15%, others 5.8% 
19
                                                
 
Source: Own calculations 
 
The two reference scenarios demonstrate the relevance of large vs. small firms for the growth of R&D 
investment volumes per sector group. While the assumption of the growth rate of small firms seems to be 
sensitive for the simulation results obtained for high R&D intensity sectors (and to some extent for firms 
belonging to low R&D intensive sectors too), the medium R&D-intensive sectors appear to be driven more 
by large firms. The latter can be seen from the increasing share of medium R&D-intensive sectors (par-
ticularly medium-high) as expected in case of R-II (see Figure 3 above), which is due to the assumed 
growth rate of 7.1% in R-II (the same for all companies regardless of firm size) compared to 5.8% for 
large firms in R-I.19 The same can be seen from the figures for the low R&D intensity sector: The expected 
volume of R&D investment depends on the assumed growth rate of small companies rather than the one 
for large firms.  
 
19  For instance, compared to the figures given by SB-2010, Automotive and Parts sector is either expected to increase its R&D investment share by 3% in case of R-II or to decrease by the 
same amount in case of R-I, both indicating the relevance of large firms in the sector.  
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Figure 3: Simulated EU Industrial R&D Scoreboard for 2020 – Scenario results 
 EU: Scenario A (€221bn)
grow th p.a.: small f irms 10%; other 5.8% 
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S-A results appear similar to  
Reference Scenario R-I (see above)  
 
Compared to SB 2010: 
S-A suggests that high-tech sectors (especially 
Pharmaceuticals & Biotech) as well as low-tech 
industries may increase their sectoral shares 
on overall R&D investment in the EU-27; me-
dium-tech sectors (esp. Automotive & Parts) 
tend to decrease   
S-B: SMEs on fast growth track until 2020…  
 
Compared to SB 2010: 
According to S-B, the assumed fast growth 
track of small firms is expected to lead to a 
moderate shift in terms of shares on overall 
R&D investments in EU-27 from medium to-
wards high-tech sectors (thus underlining the 
importance of small firms, particularly for 
Pharmaceuticals & Biotech sector). Neverthe-
less, the magnitude of the increase in R&D 
investments remains relatively small given the 
assumed fast growth scenario of 20% p.a. 
(R&D growth +3% compared to S-A and only 
+2% compared to R-I). Moreover, the distance 
in terms of sectoral composition of R&D in-
vestments compared to the US remains virtu-
ally the same.  
S-C: 30% p.a. growth for SMEs until 2020…  
 
Compared to SB 2010: 
S-C represents the most optimistic growth 
scenario. In fact, the simulated R&D invest-
ments for year 2020 are 90% above the fig-
ures of SB 2010 with the most significant 
increase expected for the high-tech sectors 
(+140%). In parallel, the importance of me-
dium-tech sectors for corporate R&D in Europe 
seems to be decreasing.  
 
Nevertheless, the scenario illustrates that even 
under the assumption of extreme growth in 
small R&D-intensive companies over a compa-
rably long period (as assumed in S-C) the sec-
tor composition of business R&D in Europe is 
not changing fundamentally. In this regard, 
large firms seem to matter more (small firms' 
growth appears relevant only in some high-
tech sectors). 
 
 
Source: Own calculations 
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EU: Scenario B (€228bn)
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When further disaggregating the sector groups, the underlying company characteristics become more evi-
dent and, however, it seems that – across all simulated scenarios – corporate R&D in the EU appears to be 
driven by both small and large firms in a more or less balanced way (see in this regard the almost negli-
gible differences among the projection results for R-I and R-II for the majority of sectors). Exceptions only 
seem to be given by some high R&D intensive sectors (esp. Pharmaceuticals & Biotechnology) as well as 
by the low R&D intensive sectors20 (both more driven by small firms) and the Automotive & Parts sector 
(mainly driven by large firms). 
 
6 Conclusions  
The bullet points below summarize the main conclusions, some stylised facts, and policy implications aris-
ing from the analysis of the empirical results illustrated above. 
 The projected scenarios – distinguished according to the assumed growth of small R&D intensive 
companies – suggest that corporate R&D spending by the EU Scoreboard companies will be rising by a 
total of 70 – 90% until 2020, compared to the figures from SB-2010 (see scenarios S-A and S-C, re-
spectively).  
 The ratio of Business sector Expenditure on R&D [BERD]/GDP in the EU-27 – as empirically resulting 
from the scenario analysis & subject to further assumptions concerning the SB~BERD R&D investment 
multiplier and the growth of the EU-27 GDP – is expected to increase up to 1.6 – 2.0% in 2020 and 
may be about to reach the Europe 2020 target,21 if the most optimistic firm growth scenario and the 
lowest scenario concerning GDP growth both turn out to be true at the same time. One should note, 
however, that these two conditions somewhat contradict each other (see discussion in chapter 4.3). In 
this regard, recalling the underlying assumptions of the corresponding scenarios may give reason to 
believe that a BERD/GDP ratio in the middle or even at the lower end of the anticipated bandwidth 
would be more realistic.22 This message would be further reinforced if the scenario analysis had been 
technically refined by addressing some methodological threats outlined in chapter 4.3, which in sum 
have the tendency to expect empirical results as low as the most optimistic scenario S-3.  
 The share of high R&D- intensive sectors in terms of total expenditure on R&D in Europe (as far as 
captured by the SB) is assumed to be increasing from 34% in SB-2010 up to at least 37% (S-A) and 
possibly even 43% given the highest growth scenario (S-C). In turn, the shares of low- and medium-
low R&D-intensive sectors are expected to remain virtually unchanged (i.e. they are independent of 
the assumed firm growth scenarios). Accordingly, depending on the corresponding scenario assump-
tions, a gradual shift from medium-high towards high R&D intensive sectors should be expected for 
business expenditure on R&D in the EU.23  
                                                 
20  The statement concerning the 'driving forces of low R&D-intensive sectors' should be treated with caution since those firms belonging to low R&D-intensive sectors which are listed in the 
R&D Scoreboard – due to the very nature of this scoreboard including the top R&D investors only – could well be seen as fairly exotic and therefore not representative of the entire low 
R&D-intensive sector. Hence, generalizing from the findings concerning these (few) firms to the sector characteristics seems to be questionable and the corresponding empirical evidence 
will therefore not be further stressed hereinafter.  
21  3% of GDP will be spent on R&D, 2/3 of which is expected to come from the business sector. 
22  In the drafting of the scenarios a number of strong assumptions have been made, which in sum tend to overestimate the increase of R&D spending rather than underestimate it. For 
instance, sector belongings have been neglected, thus assuming that growth rates as evident in emerging sectors may also apply to others, and moreover, R&D intensities have been as-
sumed to remain constant, which appears somewhat implausible, particularly with regard to SMEs that report high R&D spending while having sales close to zero (which together results in 
very high R&D intensities). In fact, such companies are more likely to either be absorbed or go bankrupt during the period under investigation rather than enter a sustainable fast growth 
track. See Ortega-Arquiles et al (2009) in this regard. 
23  Admittedly, the high R&D-intensive sectors are expected to top the medium-high sectors in terms of total R&D spending only if the most optimistic growth scenario (S-C) is assumed to 
come true. With growth scenarios below the S-C assumptions, the shift from medium to high-techs may take even longer. 
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 As the scenarios considered vary according to the underlying assumptions concerning small firms' 
growth, the magnitude of the differences in the results gives a good grasp of the importance of small 
vs. large firms for certain sectors. The results suggest that supporting the growth of SMEs may help to 
significantly leverage spending on corporate R&D in high R&D-intensive sectors like Pharmaceuticals 
& Biotech (and in some low R&D intensive industries too). Other sectors are apparently more driven by 
large firms (e.g. Automotive & Parts) and the assumed growth of smaller firms does not really affect 
the overall sector figures (at least not concerning the simulated SB-2020). In a third group of sectors 
the corporate R&D in the EU obviously depends on both small and large firms to more or less the 
same extent.  
 
The results presented above imply that the importance of high-tech sectors in Europe (evident from in-
vestment in corporate R&D) is assumed to be rising towards the figures known from the US economy; al-
though it does not reach the corresponding US level.24 Therefore, the structural gap in terms of R&D in-
vestment between Europe and the US is not expected to close until 2020; at least not if it is assumed to 
be driven by small firms' growth.  
We can conclude that, if one expects (R&D-intensive) small firms to be a driving force for a substantial 
structural change in the European economy, from being driven by medium-tech sectors towards a high-
tech based economy, it requires either a significant longer time horizon for the assumed fast growth track 
than the simulated 10 years, or small firms' growth figures even exceeding the annual 30% assumed (as 
in Scenario-C). Neither case appears to be particularly realistic.  
In short, Europe needs more top R&D investors to further intensify their engagement in R&D (increasing 
volume and R&D intensity) as well as numerous small firms that start and/or significantly increase their 
existing R&D activities and seek to become larger and (global) leading R&D investors. Accordingly, a broad 
R&D and innovation (policy) strategy is needed with policy interventions targeting all these options; i.e. 
stimulating firm growth and R&D and innovation intensity across firm size classes with individually differ-
entiated policy instruments.  
This study confirms the importance of the growth of smaller and large companies for revitalising the EU 
economy (towards being more knowledge intensive) through organic and sustainable growth; i.e. the coex-
istence of competitive firms which enjoy either a high or a moderate level of growth achieved in a shorter 
or longer time-frame, and ignoring different firm size classes. In this light we could recall that in a highly 
dynamic growth scenario the allocation of resources and the distribution of growth rates are dynamic too, 
which implies that the best performing firms expand while those under-performing shrink, with a contem-
poraneous creative destruction (growth and decay) process. Policy meant to support firm growth in gen-
eral should take this into account and allow such kinds of creative destruction phenomena to happen.25 
 
 
 
 
 
 
                                                 
24  According to the SB-2010 figures, the high R&D-intensive sectors in the US stand for c. 68% of total R&D spending in the US (see Figure 1, above) and – even if the most optimistic sce-
nario for SB-2020 comes true – the share foreseen for high R&D-intensive sectors in Europe only goes up to 43%.  
25  See for instance Caballero and Hammour 2000, Bravo-Biosca, 2010 for corresponding cost adjustments, particularly with regard to poorly functioning labour markets with high unemploy-
ment rates. 
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APPENDIX I: Fast growing companies in SB 
 
Definition of 'fast growing' companies 
Following the definition by OECD-EUROSTAT (2005), a company is classified as being a 'fast-growing' if in 
each year in a consecutive three-year period a minimum of 20% increase in either sales or employment is 
achieved. 
    
Descriptive Statistics 
Pooling several annual editions of the Scoreboard provides longitudinal samples of R&D-intensive compa-
nies. See Tables A1 and A2 below for some descriptive statistics of 'fast-growing' firms in SB (polled SB 
sample SB 2010 + SB 2006, namely S-2, see Appendix II for details).   
The sample – due to a sample selection bias towards large firms – tends to crowd out many small firms 
engaged in corporate R&D, which are just under the minimum R&D investment threshold although they 
are highly R&D-intensive given their R&D ~ sales ratios.26 This very nature of a Scoreboard (i.e. comprising 
companies being selected according to an absolute number) also has a potential impact on considerations 
of firm growth/firm histories. In fact, small companies are more often associated with the term 'fast-
growing companies', about to become large companies. In other words, capturing this type of companies 
in an SB is a matter of picking them in the right moment (once they have grown above the minimum entry 
threshold and before they reach major limiting barriers to their growth, such as e.g. market saturation). On 
the other hand, large/mature companies are usually assumed to grow at slower rates (but steadily), which 
altogether may lead to the belief that among the companies listed in the SB only a limited number might 
be classified as 'fast-growing'.  
In fact, descriptive statistics can demonstrate the opposite (at least with regard to Europe, where the fast 
growth companies tend to be the smaller firms, while remaining above the threshold of being classified as 
SME) while in the RoW fast-growing companies appear to be at the upper end of the firm size distribu-
tion). These findings support the assumption of differences in growth paths between small and large firms 
and the assumption of a significantly higher (average) annual growth rate for the SMEs (in this light, see 
the SME growth scenarios developed above).   
The evidence from Table 1 below suggests that fast-growing companies are mainly linked to only three 
sectors, whereas companies belonging to the remaining sectors tend to follow a rather smooth growth 
path (i.e. few/no fast-growing firms). Hence, further (add-on) considerations of fast-growing companies 
may concentrate on these three sectors, namely Pharmaceuticals & Biotechnology, Software & Computer 
Services, and Technology Hardware & Equipment.  
Moreover, given the number of fast-growing companies compared to the total number of companies in 
the corresponding sector as presented in Table 1, Healthcare Equipment & Services stands out and there-
fore deserves a closer look. Interestingly enough, a number of fast-growing companies (in terms of sales 
and to some extent with regard to R&D investment too) were found among the Oil & Gas Producers in the 
SB. However, the evidence suggests that EU firms miss this emerging trend. 
In contrast, in the Electronic & Electrical Equipment Sector as well as in Industrial Engineering, only com-
parably few companies were identified as fast-growing although the overall population of companies in 
these two sectors accounts for about 15% of all SB companies. This is quite surprising since both sectors 
are commonly assumed to develop rather dynamically. Nevertheless, there are at least some companies 
in both sectors characterised by notable R&D investment growth, and among them – in both sectors – the 
EU companies outnumber those from US and RoW together. 
                                                 
26  Moreover, there is also a geographical bias due to differences in the sample coverage when focusing on the main R&D investors globally rather than EU-wide only. This tends to result in 
smaller companies being crowded out with rising geographical coverage. 
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There are almost no fast-growing companies at all in Automobiles & Parts (if anything at all appears no-
table it might be the fact that there are some companies in this sector characterised by fast-growing R&D 
investment and – with only one exception – they are all from Asia). 
Table A1:  Frequency and sector alignment of companies identified as fast-growing 
[pooled Scoreboard sample; growth criteria: sales, employment, and R&D] 
 
   
SB 2010 
(reference) 
Fast-growing 
companies 
[acc. to sales]* 
Fast-growing 
[employment 
growth]* 
Fast-growing 
[R&D invest-
ment]* 
Sector of activity Freq % EU US RoW EU US RoW EU US RoW 
Aerospace & Defence 55 2.75 3 1  2   1 3  
Alternative energy 15 0.75 2 1  5 1  4 1 1 
Automobiles & Parts 104 5.20 1  2    1  5 
Banks 35 1.75       3  1 
Beverages 6 0.30       2  1 
Chemicals 114 5.70      1 2  1 
Construction & Materials 62 3.10 1  1 1      
Electricity 29 1.45       2   
Electronic & Electrical Equipment 149 7.45 4  7 3 2 1 7 2 4 
Fixed Line Telecommunications 21 1.05         1 
Food & Drugs Retailers 8 0.40          
Food Producers 54 2.70          
Forestry & Paper 9 0.45          
Gas, Water & Multi-utilities 13 0.65 1         
General Industrials 52 2.60    1 1 1   1 
General Retailers 18 0.90  3      2  
Healthcare Equipment & Services 67 3.35 4 8 1 2 2  1 6 1 
Household Goods 37 1.85 1  1    2   
Industrial Engineering 157 7.85 1 1 1 1   8 2 3 
Industrial Metals 28 1.40 1      1  1 
Industrial Transportation 14 0.70          
Leisure Goods 35 1.75   1  1 1  1 2 
Life Insurance 5 0.25 1         
Media 20 1.00       2   
Mining 9 0.45 1  1    1  1 
Mobile Telecommunications 8 0.40          
Nonlife Insurance 9 0.45 1   1   1   
Oil & Gas Producers 27 1.35 1 3 5     1 2 
Oil Equipment, Services & Distribu- 17 0.85 1  1       
Other financials 25 1.25 1 1     3   
Personal Goods  30 1.50 1   1      
Pharmaceuticals & Biotechnology 243 12.15 14 20 2 14 6 1 14 7 3 
Software & Computer Services 188 9.40 12 10 4 8 10 2 11 9 6 
Support Services 44 2.20 2      3 1  
Technology Hardware & Equipment 255 12.75 8 7 10 4 10 4 5 18 8 
Tobacco 6 0.30          
Travel & Leisure 32 1.60 2         
                                                   total   64 55 37 43 33 11 74 53 42 
Total  2000  100 156 87 169 
*  Number of companies classified according to the 'fast-growing' criterion as defined above (in three consecutive 
years a minimum of 20% annual growth). 
 
NB: Sectors with frequency above 5% in the SB are highlighted in grey. 
 
In general it can be stated that fast growth in terms of R&D investment was detected in those sectors 
where fast-growing sales/employment figures were also found. However, the Alternative Energy sector, 
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together with Banks and Other Financials, seems to be an exception in this regard as there are several 
firms characterised by fast (and steady) R&D investment growth while they are not growing as fast in 
terms of sales and/or employment. Presumably the latter is still to come when the companies reap the 
benefits of their strongly increased engagement in corporate R&D.   
 
Table A2:  Descriptive statistics of fast-growing firms' characteristics  
[EU vs. US and the rest of the world] 
 
Table A2.1: according to sales growth criterion 
  all firms Fast-growing 
firms in EU 
Fast-growing 
firms in US 
Fast-growing 
firms in RoW 
Variable Median Std. dev. Median Std. dev. Median Std. dev. Median Std. dev.
R&D (abs.) 35.1 171.9 12.9 26.0 53.6 239.7 73.8 151.5
Employees 1251.0 54353.0 608.0 19935.1 1328.0 19027.9 9452.0 112537.8
Net Sales 357.0 26782.6 138.1 6498.7 338.9 39903.1 2465.5 23325.0
Operating Profits 33.4 4449.0 8.5 683.6 31.7 6567.9 228.9 4381.2
Capital Expenditure 16.0 2511.0 4.0 665.1 19.3 2485.8 113.0 3927.2
R&D intensity (% sales) 0.09 3.5 0.09 3.6 0.15 3.6 0.03 0.1
No of individuals 2000  64 55 37 
Note:  Median is reported instead of Mean since the companies appear to be very heterogeneous (technically, the distribution is 
fat tailed) and providing an average across all firms could lead to meaningless numbers due to the weight of the 'outliers'.  
 
When looking at SB companies characterised as 'fast-growing' according to their sales figures, the evi-
dence from Table A2.1 suggests that in the RoW large firms are growing the most, thus being character-
ised by a comparably low R&D intensity. In the EU this is vice versa; i.e. fast-growing firms tend to be 
much smaller, but highly R&D-intensive. In the US the fast-growing companies tend to be highly R&D-
intensive too (with 15% vs. 9% of sales invested in R&D, more than in the EU), but compared to European 
firms they appear to be larger in terms of staff, net sales and profits (by factors 2, 2.5 and 4, respec-
tively) and on average they also invest much more in R&D in absolute terms compared to European firms 
(4 times more).   
In general, there are less fast-growing companies in terms of employment compared to the number of 
firms found with fast-growing sales (this applies in particular to the RoW region).  
 
Table A2.2: according to employment growth criterion 
  all firms Fast-growing 
firms in EU 
Fast-growing 
firms in US 
Fast-growing 
firms in RoW 
Variable Median Std. dev. Median Std. dev. Median Std. dev. Median Std. dev. 
R&D (abs.) 33.4 208.0 12.6 22.6 80.1 286.3 113.6 138.3 
Employees 1332.0 20873.5 340.0 2907.7 2064.0 8823.2 8196.0 52388.9 
Net Sales 352.4 2860.2 103.0 616.5 616.2 3213.1 1969.9 4509.1 
Operating Profits 24.6 586.6 7.0 112.8 43.0 867.9 257.1 427.5 
Capital Expenditure 13.1 251.6 3.0 114.9 35.0 208.8 79.6 506.2 
R&D intensity (% sales) 0.12 23.0 0.10 34.5 0.15 0.5 0.08 0.08 
No of individuals 2000  43 33 11 
Note:  Median is reported instead of Mean since the companies appear to be very heterogeneous (technically, the distribution is 
fat tailed) and providing an average across all firms could lead to meaningless numbers due to the weight of the 'outliers'.  
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The differences between fast-growing firms in the EU compared to those in the US and in the RoW as de-
scribed above in relation to Table A2.1 become even clearer when looking at companies characterised by 
significant employment growth (see Table A2.2). Fast-growing firms from the EU appear to be even 
smaller in terms of staff and net sales than outlined above. The median fast-growing EU firm is just 
above the size of an SME (~ 340 employees)27 while the median US firm has six times more staff and 
companies in the RoW, sometimes even 24 times more. Similar figures result for all other company char-
acteristics. 
Finally, the reported R&D intensity of fast-growing companies in the EU and the US are virtually the same 
in Table A2.1 and A2.2 regardless of whether fast growth in terms of sales or employment is the matter 
of interest. In fact, fast-growing companies from US appear to be extremely R&D intense, while those 
from the EU still have a fairly high R&D intensity – although already much less compared to those in the 
US – and the lowest R&D intensity is found with regard to the RoW companies. However, the differences 
in R&D/sales ratio of the RoW firms compared to those in EU and US appear smaller in Table A2.2 than 
above in Table A2.1 which might indicate that significant employment growth (in contrast to significant 
sales growth) in the RoW is also linked to R&D intensity. A more detailed discussion of the impact of R&D 
on employment can be found in Acs (2008) or related to Scoreboard data in Bogliacino (2010).  
 
APPENDIX II: SMEs in Scoreboard  
 
Pooled data - general remarks 
The amount of information available on European firms, in particular broken down by company size 
classes and activities, is surprisingly low. Admittedly, some data is available, and EUROSTAT, the OECD 
and others have recently made notable efforts to improve data availability, especially on SMEs. However, 
particularly as regards small and micro-enterprises (together they account for about 50% of the EU-25 
value added), these databases are rather fragmented and often no more than anecdotal evidence. Unfor-
tunately, this applies even more so where company activities are a point of interest, for instance R&D and 
innovation in SMEs.  
Characteristics of the three SME samples created from Scoreboard data:  
 (1)  A mainly28 balanced panel has been filtered out from the "1375 SB 09-02" data set, which com-
prises a merger of the SB's from 2006 and 2010 and contains only those firms (1,375 in total) 
which happen to appear in both data sets. In total 89 SMEs could be identified from this sample, 
hereinafter called S-1 (10 companies from US, the rest from the EU).  
(2) S-2 constitutes an unbalanced panel of altogether 160 SMEs out of the 2,000 companies listed 
in SB-2010. In order to create this sample, starting from the 2,000 companies listed in SB-2010 
and going backwards in time to observations for 2002, the initial data set has been comple-
mented by including data from earlier SB waves, thus accepting that the panel created will be un-
balanced (increasingly lacking observations for earlier years). 27 of the 160 SMEs are from 
US/RoW, the remaining 133 from the EU. 
(3)  S-3: An unbalanced panel of a total of 398 SMEs has been created, resulting from a merger of 
all SB waves published so far (SB-2004 until SB-2010). For this exercise, from every single SB, the 
companies to be classified as an SME in at least one year (see definition below) have been filtered 
out. By this means a list of companies has been created comprising those SB companies which 
were an SME in at least one year of there listing in any of the SB. For all these companies the 
                                                 
27  Definition of an SME: >250 employees and net sales <50mill Euros within a given year. See: http://ec.europa.eu/enterprise/policies/sme/facts-figures-analysis/sme-definition/index_en.htm  
28  "Mainly balanced" means that there are indeed some blanks in this data set although the panel can be considered as "balanced". In fact, the corresponding blanks do not refer to missing 
data rather than to the non-existence of the corresponding observation, i.e. a certain company may simply not have existed in an earlier year of a certain SB wave (but was included in a 
later year of the same wave since it has grown into a leading R&D investor) or the company was included in the SB 2006 and in SB 2010, but had to be dropped due to a merger or acqui-
sition. 
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data from all SB waves was then merged (in case of overlapping data, coverage priority was al-
ways given to the information from the most recent SB). For merging observations from compa-
nies not reporting in Euros and taken from different SB waves, monetary values were first trans-
ferred into the original currency (using the exchange rate as provided in the corresponding SB) and 
thereafter – by using the conversation rate from SB-2010 – values were turned into 2010 Euros 
(see exchange rate adjustments as described above). Overall, there are 84 from rest of the world 
countries (76 from the US), and 314 from the EU (among them 155 companies from the UK!).29 
 
Please note that for the simulation purposes presented above S-2 was used! 
See below for complementary descriptive statistics. 
Table A3:  Sector alignment of large firms and SMEs in pooled Scoreboard samples  
   
SB 2010 
(reference) 
balanced 
panel 
 (S1) 
pooled SB 
2010 sample 
(S2) 
Pooled SB 04-
10 sample 
 (S3) 
ICY CLASS all SB firms SMEs SMEs SMEs 
Sector of activity Freq % Freq % Freq % Freq % 
Aerospace & Defence 55 2.75    1 0.63 3 0.75 
Alternative energy 15 0.75 1 1.12 2 1.25 3 0.75 
Automobiles & Parts 104 5.20 1 1.12 3 1.88 5 1.26 
Banks 35 1.75       3 0.75 
Beverages 6 0.30          
Chemicals 114 5.70    2 1.25 3 0.75 
Construction & Materials 62 3.10          
Electricity 29 1.45       2 0.50 
Electronic & Electrical Equipment 149 7.45 5 5.62 8 5.00 21 5.28 
Fixed Line Telecommunications 21 1.05          
Food & Drugs Retailers 8 0.40          
Food Producers 54 2.70          
Forestry & Paper 9 0.45          
Gas, Water & Multi-utilities 13 0.65          
General Industrials 52 2.60          
General Retailers 18 0.90       1 0.25 
Healthcare Equipment & Services 67 3.35 3 3.37 5 3.13 18 4.52 
Household Goods 37 1.85          
Industrial Engineering 157 7.85 2 2.25 4 2.50 9 2.26 
Industrial Metals 28 1.40          
Industrial Transportation 14 0.70          
Leisure Goods 35 1.75    1 0.63 5 1.26 
Life Insurance 5 0.25          
Media 20 1.00       2 0.50 
Mining 9 0.45       1 0.25 
Mobile Telecommunications 8 0.40    1 0.63 2 0.50 
Nonlife Insurance 9 0.45 1 1.12 1 0.63 1 0.25 
Oil & Gas Producers 27 1.35          
Oil Equipment, Services & Distribu- 17 0.85       2 0.50 
Other financials 25 1.25          
Personal Goods  30 1.50          
Pharmaceuticals & Biotechnology 243 12.15 46 51.69 91 56.88 194 48.74 
Software & Computer Services 188 9.40 21 23.60 27 16.88 80 20.10 
Support Services 44 2.20    1 0.63  2 0.50 
Technology Hardware & Equipment 255 12.75 9 10.11 12 7.50 34 8.54 
Tobacco 6 0.30          
Travel & Leisure 32 1.60    1 0.63 7 1.76 
                                                 
29  There seems to be a certain bias towards SMEs from the UK since about 50% of the firms from the EU are from the UK. 
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Total  2000  100 89 100 160 100  398 100 
 
Table A4: Descriptive statistics of firm characteristics 
  All firms in SB 
2010# 
 
SMEs in S1# 
 
SMEs in S2# 
 
SMEs in S3# 
Variable Mean Std. 
Dev. 
Mean Std. 
Dev. 
Mean Std. 
Dev. 
Mean Std. 
Dev. 
R&D investment (abs.) 196.1 598.4 20.8 23.0 17.3 19.3 16.7 18.0 
Employees 22961.0 51470.1 272.1 395.7 198.3 312.8 201.7 284.8 
Net Sales 6446.9 16965.9 59.7 113.0 39.6 88.7 36.6 74.4 
Operating Profits 744.4 2479.0 -6.6 32.6 -11.4 29.7 -13.5 31.3 
Capital Expenditures 455.2 1554.3 2.9 6.8 3.3 16.4 3.0 12.6 
R&D Intensity (% sales) 10.1 404.4 4.7 13.9 11.7 53.2 12.9 66.0 
No of individuals 2000  89 160 398  
*  Figures for 2007!  
Note: The choice of a certain year for the descriptive statistics might be arbitrary; but – by choosing 2007 – a potential impact/bias intro-
duced due to the financial and economic crisis should be avoided.  
 
 
Table 5: Descriptive statistics of SMEs in the SB 2010 sample (S2) 
- broken down by R&D intensity groups; non-EU firms NOT included - 
  
 
High-tech 
 
Medium-high 
 
Medium-low 
 
Low 
R&D investment (abs.) Media 8.11 4.21 2.64 1.91 
 St. dev 16.67 2.66 1.70  
R&D Intensity (% sales) Median 0.72 0.08 0.02 0.00 
 St. dev 3.46 0.09 0.01  
Employees Median 109.00 152.50 62.50 490.00 
 St. dev 365.71 120.65 10.50  
Net Sales Median 15.88 38.24 15.63 779.07 
 St. dev 71.43 30.25 15.52  
Operating Profits Median -7.85 1.48 4.01 155.88 
 St. dev 19.99 18.49 11.72  
Capital Expenditures Median 0.60 0.90 0.55 2.03 
 St. dev 3.53 1.24 0.19  
 No. of obs. 110 20 2 1 
 
Beyond the differences between small and large companies as illustrated, for instance, in chapter III 
above and by means of Table A3 and A4, Appendix, there seems to be some dissimilarity among SMEs, 
particularly with regard to R&D intensity, net profits, and employment. But when taking the magnitude 
and the corresponding standard deviations of R&D investment, net sales, and capital expenditures of 
SMEs into account, they appear throughout to be relatively low, which in turn suggests a rather uniform 
picture in this respect. Nevertheless, there are indeed some notable differences among the three SME 
samples, most likely resulting from the procedures applied in terms of the sample selection/data process.  
In general, S-1 consists of SMEs listed in the Scoreboards over the entire period under consideration, 
which allows the assumption that these firms are either examples of a successful growth path (growing 
from small into large scale companies) or of a successful market niche strategy, both relying on high R&D 
intensity as part of the business concept.30 In contrast, in S-2 and even more in S-3 there are numerous 
                                                 
30  Following the taxonomy of R&D-intensive SMEs as developed in Ortega-Argilés, Potters and Voigt (2009), IRI WP, 15/2009 <link>, S-1 apparently constitutes a major extent of either 
steady/growing 'niche market producers' or 'gazelles' relying on R&D intensive businesses rather than the 'corporate laboratory' type of SMEs. This hypothesis is supported by the notable 
differences between S-1 and S-2/S-3 in terms of the average number of employees and net sales.  
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SMEs which 'come and go', i.e. they appear in just one of the latest SB waves (growing into it) or are in-
cluded in one or several early SB waves only, but disappear at a certain point in time, most likely due to 
M&A, bankruptcy, shrinking R&D intensity, etc. Hence, with a look at the number of these cases (see the 
difference in absolute numbers of SMEs in S1 and S3), there is good reason for further analysing the cor-
responding firm paths, which is due to be done in ongoing studies carried out by the JRC-IPTS IRI team 
(Economics of Industrial Research and Innovation). 
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Abstract 
The paper investigates how sector composition and the magnitude of R&D investment in the EU may differ in 2020 in comparison 
to the past, if a selection of top R&D-investing SMEs were assumed to be on a fast growth track while the top R&D-investing large-
scale companies continue to grow as before. The background of this research objective is the emerging focus on SMEs – and in 
particular the fast-growing among them – with regard to the "Europe 2020" policy strategy. The study relies on the sample of top 
R&D-investing firms as given by the latest available "EU Industrial R&D Investment Scoreboard" editions, building there from an
unbalanced panel. Scenarios were developed by distinguishing SMEs' assumed growth paths vs. that of large scale companies. A 
linear prediction model has been used to calculate the scenario simulations. 
 
 
 
Overall, the study indicates that if one expects the (R&D-intensive) small firms to be a driving force for a substantial structural 
change in the EU economy, from being driven by medium-tech sectors towards a high-tech based economy, it requires either a 
significant longer-term horizon of the assumed fast growth track than the simulated 10 years, or small firms' growth figures which 
even exceed the assumed annual 30% (as in the most optimistic scenario). Neither case appears to be particularly realistic. Hence, 
we need more top R&D investors in Europe to further intensify their engagement in R&D (increasing volume and R&D intensity) as 
well as numerous small firms that start and/or significantly increase their existing R&D activities and thus seek to become large 
firms and (global) leading R&D investors. Accordingly, a broad R&D and innovation (policy) strategy is needed with policy 
interventions which also target well all these options; i.e. stimulating firm growth and R&D and innovation-intensity across firm-
sized classes.  
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As the Commission’s in-house science service, the Joint Research Centre’s mission is to provide EU 
policies with independent, evidence-based scientific and technical support throughout the whole policy 
cycle. 
 
Working in close cooperation with policy Directorates-General, the JRC addresses key societal chal-
lenges while stimulating innovation through developing new standards, methods and tools, and shar-
ing and transferring its know-how to the Member States and international community. 
 
Key policy areas include: environment and climate change; energy and transport; agriculture and food 
security; health and consumer protection; information society and digital agenda; safety and security 
including nuclear; all supported through a cross-cutting and multi-disciplinary approach. 
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